查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1122614

牙科生物材料的全球市場預測(2022年～2027年)

Dental Biomaterial Market - Forecasts from 2022 to 2027
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 155 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球牙科生物材料的市場規模，在預測期間內預計以10.38％的年複合成長率成長，從2020年的71億6,300萬美元，到2027年達到142億9,600萬美元。

牙科疾病的盛行率增加加上人工植牙的普及率上升，促預計進在預測期間內的市場成長。可是，嚴格法規和臨床流程，預計抑制今後數年的市場成長。

本報告提供全球牙科生物材料市場相關調查分析，市場概要，促進因素和阻礙因素，各材料、各用途、各終端用戶、各地區的市場分析，競爭資訊和企業簡介等資訊。

目錄

第1章 簡介

  • 市場概要
  • COVID-19設想情境
  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 新加入業者的威脅
    • 替代品的威脅
    • 在產業的競爭關係
  • 產業的價值鏈分析

第5章 全球牙科生物材料市場:各材料

  • 簡介
    • 金屬系生物材料
    • 鈦
    • 不鏽鋼
    • 其他
  • 陶瓷系生物材料
  • 高分子系生物材料
  • 其他

第6章 全球牙科生物材料市場:各用途

  • 簡介
  • 植入
  • 補綴
  • 牙齒矯正
  • 其他

第7章 全球牙科生物材料市場:各終端用戶

  • 醫院
  • 診療所
  • 學術研究機關

第8章 全球牙科生物材料市場:各地區

  • 簡介
  • 北美
    • 北美的牙科生物材料市場:各材料(2020年～2027年)
    • 北美的牙科生物材料市場:各用途(2020年～2027年)
    • 北美的牙科生物材料市場:各終端用戶(2020年～2027年)
    • 各國
  • 南美
    • 南美的牙科生物材料市場:各材料(2020年～2027年)
    • 南美的牙科生物材料市場:各用途(2020年～2027年)
    • 南美的牙科生物材料市場:各終端用戶(2020年～2027年)
    • 各國
  • 歐洲
    • 歐洲的牙科生物材料市場:各材料(2020年～2027年)
    • 歐洲的牙科生物材料市場:各用途(2020年～2027年)
    • 歐洲的牙科生物材料市場:各終端用戶(2020年～2027年)
    • 各國
  • 中東、非洲
    • 中東、非洲的牙科生物材料市場:各材料(2020年～2027年)
    • 中東、非洲的牙科生物材料市場:各用途(2020年～2027年)
    • 中東、非洲的牙科生物材料市場:各終端用戶(2020年～2027年)
    • 各國
  • 亞太地區
    • 亞太地區的牙科生物材料市場:各材料(2020年～2027年)
    • 亞太地區的牙科生物材料市場:各用途(2020年～2027年)
    • 亞太地區的牙科生物材料市場:各終端用戶(2020年～2027年)
    • 各國

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併，收購，契約，及合作
  • 供應商的競爭力矩陣

第10章 企業簡介

  • Straumann AG
  • Royal DSM
  • Geistlich Pharma AG
  • ZimVie Inc
  • 3M Company
  • Dentsply Sirona, Inc
  • Kuraray Co., Ltd
  • Mitsui Chemicals, Inc
  • DMP Dental Industry S.A
簡介目錄
Product Code: KSI061613715

The global dental biomaterial market is expected to grow at a CAGR of 10.38% over the forecast period to reach a total market size of US$14.296 billion by 2027, increasing from US$7.163 billion in 2020.

Dental biomaterials include all types of natural and biocompatible synthetic materials used to restore damaged and decayed teeth. The increasing prevalence of dental disorders coupled with the rising penetration of dental implants is expected to drive the growth of the market during the forecast period. However, stringent regulation and the clinical process are anticipated to restrain the growth of the market in the coming years.

Dental implants and prosthetics are mostly used either for filling oral cavities or replacing them with a concrete solution and according to the World Health Organization, more than 3 billion people in the world are affected by oral health problems. A dental implant is a kind of oral prosthetic in which the gum is opened and in the cavity is positioned a prosthetic crown. Planning the position and number of implants is key to the long-term health of the prosthetic since biomechanical forces created during chewing can be significant.

The growing geriatric population is driving the growth of the market

The global population is ageing, and every country is experiencing growth in the old age proportion of elderly people in the total population. Poor oral health among older people is evident in a high level of tooth loss, and all types of periodontal disease. According to the recent report titled World Population Prospects by the United Nations, by 2050, one in every six people in the world will be over age 65 (16%), from one in 11 in 2019 (9%) and the number of people aged 80 years or above is projected to triple, from 143 million in 2019 to 426 million in 2050.

Material analysis

By material, the dental biomaterial market has been segmented into metallic biomaterials, ceramic biomaterials, and polymeric biomaterials, among others. The metallic biomaterial segment is projected to hold a significant share, owing to the benefits offered by titanium material, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion resistance properties.

Application insight

By application, the dental biomaterial market is segmented based on implantology, prosthodontics, and orthodontics, among other applications. The implantology application segment accounted for a significant share of the market on account of the increasing penetration of dental implants in developing countries like China, India, and Brazil. In addition, the rising demand for cosmetic dentistry, expanding dental tourism in emerging markets, coupled with increasing disposable incomes in developing countries, are further expected to boost the growth of the market in the coming years.

North America will hold a significant share in the market over the forecast period

By geography, the dental biomaterial market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. The North American region is expected to hold a significant share in the market owing to the presence of major players coupled with the growing geriatric population. In Europe, favourable government initiatives on oral healthcare, combined with increased adoption of dental biomaterials for the fabrication of implants and other dental products, are expected to drive the regional market in the coming years. Besides, rising disposable income and the growing number of dental hospitals, the market for dental biomaterials is anticipated to witness exponential growth in the Asia Pacific region.

Competitive Insights

Prominent key market players in the dental biomaterial market include Straumann AG, Royal DSM, Medtronic Plc, Danaher Corporation, Geistlich Pharma AG, Zimmer Biomet Holdings, 3M Company, Dentsply Sirona, Inc, Kuraray Co., Ltd, and Mitsui Chemicals, Inc. The number of players in the dental biomaterial market is large and growing, with the opportunity to generate significant revenues because of the growing demand for various applications. The players in the global dental biomaterial market are implementing various growth strategies to gain a competitive advantage over their competitors in this market and are now focusing on the developing region due to the rising disposable income and increasing healthcare expenditure. Key players in this market are focusing on strategic acquisitions, collaborative partnerships, and investment in new geographical boundaries as a part of their growth strategies to provide products to their consumers worldwide. For instance, in July 2018, Straumann Group acquired a nearly 30% stake in its biomaterials partner, Botiss medical AG, for an undisclosed sum. Botiss is a fast-growing, entrepreneurial company that has already become a leading provider of biomaterials for oral surgery and the acquisition agreement enables Straumann to expand its global distribution network of Botiss products. Major market players in the global dental biomaterial market have been covered along with their relative competitive positions and strategies. The report also mentions recent deals and investments by different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered, along with the recent deals and investments of these important players in the global dental biomaterial market.

Key developments in the market:

  • December 2020: Sonoma Pharmaceuticals, Inc., a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products for a variety of applications, disinfectant use, and dermatological conditions, announced its entry into a non-exclusive distribution agreement with Gabriel Science into the dental market.
  • February 2022: Ultradent Products, Inc., a global producer of high-tech dental materials and equipment, announced the launch of MTApex bioceramic root canal sealer, a new endodontic product.

COVID-19 Insights:

COVID-19 had a negative impact on the dental biomaterial market. The rise in infected cases and mandated lockdown decreased the number of patient visits to dental clinics. According to a survey conducted by Global Dental Council, approximately 69% of dental business owners reported their average monthly dental business income had declined in 2020 compared to the previous year's average monthly income. At the same time, over a third (35%) expected their income to remain lower than before COVID in the upcoming year.

Segmentation:

  • By Material

Metallic Biomaterials

  • Titanium
  • Stainless Steel
  • Other

Ceramic Biomaterials

Polymeric Biomaterials

Others

  • By Application

Implantology

Prosthodontics

Orthodontics

Others

  • By End-user

Hospitals

Clinics

Academies and Research Laboratories

  • By Geography

North America

  • United States
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Covid-19 Scenario
  • 1.3. Market Definition
  • 1.4. Market Segmentation

2. RESEARCH METHODOLOGY  

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL DENTAL BIOMATERIAL MARKET, BY MATERIAL 

  • 5.1. Introduction
    • 5.1.1. Metallic Biomaterials
    • 5.1.2. Titanium
    • 5.1.3. Stainless Steel
    • 5.1.4. Other 
  • 5.2. Ceramic Biomaterials
  • 5.3. Polymeric Biomaterials
  • 5.4. Others

6. GLOBAL DENTAL BIOMATERIAL MARKET, BY APPLICATION 

  • 6.1. Introduction
  • 6.2. Implantology
  • 6.3. Prosthodontics
  • 6.4. Orthodontics
  • 6.5. Others

7. GLOBAL DENTAL BIOMATERIAL MARKET, BY END-USER VALUE

  • 7.1. Hospitals
  • 7.2. Clinics
  • 7.3. Academies and Research Laboratories

8. GLOBAL DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 

  • 8.1. Introduction
  • 8.2. North America 
    • 8.2.1. North America Dental biomaterial Market, By Material, 2020 to 2027
    • 8.2.2. North America Dental biomaterial Market, By Application, 2020 to 2027
    • 8.2.3. North America Dental biomaterial Market, By End-User, 2020 to 2027
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America 
    • 8.3.1. South America Dental biomaterial Market, By Material, 2020 to 2027
    • 8.3.2. South America Dental biomaterial Market, By Application, 2020 to 2027
    • 8.3.3. South America Dental biomaterial Market, By End-User, 2020 to 2027
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe 
    • 8.4.1. Europe Dental biomaterial Market, By Material, 2020 to 2027
    • 8.4.2. Europe Dental biomaterial Market, By Application, 2020 to 2027
    • 8.4.3. Europe Dental biomaterial Market, By End-User, 2020 to 2027
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. Spain
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. France
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa 
    • 8.5.1. Middle East and Africa Dental biomaterial Market, By Material, 2020 to 2027
    • 8.5.2. Middle East and Africa Dental biomaterial Market, By Application, 2020 to 2027
    • 8.5.3. Middle East and Africa Dental biomaterial Market Analysis, By End-User, 2020 to 2027
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific  
    • 8.6.1. Asia Pacific Dental biomaterial Market, By Material, 2020 to 2027
    • 8.6.2. Asia Pacific Dental biomaterial Market, By Application, 2020 to 2027
    • 8.6.3. Asia Pacific Dental biomaterial Market, By End-User, 2020 to 2027
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. Indonesia
      • 8.6.4.5. Thailand
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Straumann AG
  • 10.2. Royal DSM
  • 10.3. Geistlich Pharma AG
  • 10.4. ZimVie Inc
  • 10.5. 3M Company
  • 10.6. Dentsply Sirona, Inc
  • 10.7. Kuraray Co., Ltd
  • 10.8. Mitsui Chemicals, Inc
  • 10.9. DMP Dental Industry S.A